These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22883695)

  • 1. The EMA quality guideline on the pharmaceutical development of medicines for paediatric use.
    van Riet-Nales DA; Wang S; Saint-Raymond A; Robert JL
    Int J Pharm; 2012 Oct; 435(2):132-4. PubMed ID: 22883695
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory environment for allergen-specific immunotherapy.
    Kaul S; May S; Lüttkopf D; Vieths S
    Allergy; 2011 Jun; 66(6):753-64. PubMed ID: 21288251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Packaging of medicines for paediatric use: Prescrire's constructive proposals.
    Prescrire Int; 2012 Oct; 21(131):249-50. PubMed ID: 23185854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the pharmacopoeia in the control of pharmaceutical preparations.
    Grainger HS
    Ann Ist Super Sanita; 1975; 11(3-4):305-13. PubMed ID: 1234732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.
    Seyberth HW; Demotes-Mainard J; Wrobel P
    Pediatr Nephrol; 2005 Nov; 20(11):1537-40. PubMed ID: 16167134
    [No Abstract]   [Full Text] [Related]  

  • 7. Inspections: the international regulatory view.
    Turner JL
    PDA J Pharm Sci Technol; 1994; 48(4):180-1. PubMed ID: 7804815
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmaceutical product quality control and good manufacturing practices].
    Hiyama Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):1-16. PubMed ID: 21381389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New pharmaceutical legislation in Italy and Federal Republic of Germany in relation to European Economic Community directives].
    Cavatorta L
    Boll Chim Farm; 1979 Mar; 118(3):144-62. PubMed ID: 475906
    [No Abstract]   [Full Text] [Related]  

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (970):1-235, back cover. PubMed ID: 22894011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EMA perspective: case studies from the PDCO formulations group (chemicals & biologicals).
    Lebarbier C; Esteve I
    Int J Pharm; 2012 Oct; 435(2):131-2. PubMed ID: 22883694
    [No Abstract]   [Full Text] [Related]  

  • 12. [The European directorate for the quality of medicines].
    Artiges A
    Ann Pharm Fr; 2001 Feb; 59(1):63-8. PubMed ID: 11223580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO guideline development of paediatric medicines: points to consider in pharmaceutical development.
    Kristensen HG
    Int J Pharm; 2012 Oct; 435(2):134-5. PubMed ID: 22883696
    [No Abstract]   [Full Text] [Related]  

  • 14. Inconsistencies among European Union pharmaceutical regulator safety communications: a cross-country comparison.
    Zeitoun JD; Lefèvre JH; Downing N; Bergeron H; Ross JS
    PLoS One; 2014; 9(10):e109100. PubMed ID: 25333986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National drug quality assurance system.
    Wijesekera T
    Ceylon Med J; 1993 Jun; 38(2):58-60. PubMed ID: 8370088
    [No Abstract]   [Full Text] [Related]  

  • 16. Promoting public health and protecting consumers in a global economy: an overview of HHS/FDA's international activities.
    Kelly DP; Bachorik LL
    Food Drug Law J; 2005; 60(3):339-46. PubMed ID: 16304741
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 18. Counterfeiting and piracy of pharmaceuticals.
    Grackin A
    IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
    [No Abstract]   [Full Text] [Related]  

  • 19. The European Regulation on medicines for paediatric use.
    Dunne J
    Paediatr Respir Rev; 2007 Jun; 8(2):177-83. PubMed ID: 17574163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC).
    Boterman M; Doig M; Breda M; Lowes S; Jersey J; Shoup R; Garofolo F; Dumont I; Martinez S; Needham S; Cruz Caturla M; Couerbe P; Guittard J; Maltas J; Lansing T; Bhatti M; Schiebl C; Struwe P; Sheldon C; Hayes R; Sangster T; Pattison C; Bouchard J; Goodwin L; Islam R; Segers R; Lin ZJ; Hillier J; Garofolo W; Zimmer D; Folguera L; Zimmermann T; Pawula M; Moussallie M; Teixeira Lde S; Rocha T; Tang D; Jardieu P; Truog J; Lin J; Lundberg R; Cox C; Breau A; Bigogno C; Schoutsen D; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Nicholson R; Jenkins R; Lin MH; Karnik S; De Boer T; Houghton R; Green R; DeMaio W; Sable R; Smith K; Siethoff C; Cojocaru L; Allen M; Harter T; Fatmi S; Sayyarpour F; Malone M; Best S; Fang X
    Bioanalysis; 2012 Mar; 4(6):651-60. PubMed ID: 22452256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.